Brash J L, Scott C F, ten Hove P, Wojciechowski P, Colman R W
Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.
Blood. 1988 Apr;71(4):932-9.
The transient detection of fibrinogen on surfaces has been described (Vroman effect) and high-mol-wt kininogen (HK) has been shown to play a role in this reaction. In this study, we attempted to identify the form of HK responsible for preventing detection of the fibrinogen initially adsorbed from plasma to various artificial surfaces and to determine if other plasma components were involved. We compared 125I-fibrinogen adsorption in the presence of normal plasma to plasma deficient in specific proteins. On all surfaces tested, we found that fibrinogen was displaced from the surface. The extent of displacement was greatly reduced, however, but not eliminated in HK-deficient plasma. Factor XII-deficient plasma also showed reduced fibrinogen displacement. These data indicate that HK can actually displace fibrinogen; however, factor XII, or a factor XII-mediated reaction also appears to be necessary for this displacement to occur. Furthermore, when normal plasma was first subjected to extensive contact activation by dextran sulfate, during which the HK was extensively degraded to components smaller than the light chain (as assessed by Western blotting), we observed greatly reduced displacement of fibrinogen. Extensive contact activation of Factor XI-deficient plasma failed to show low-mol-wt derivatives, however, and displacement of fibrinogen was similar to normal plasma that had not undergone extensive activation. These data indicate that HKa (active cofactor produced during contact activation by factor XIIa or kallikrein) is primarily responsible for displacing fibrinogen, and that HKi (inactive cofactor generated by factor XIa) cannot displace fibrinogen. The fibrinogen from all plasma samples looked similar by Western blot analysis, suggesting that fibrinogenolysis was not a component of the Vroman effect. In addition, experiments performed with plasma prechromatographed on lysine agarose showed that a lysine-agarose adsorbable protein may be minimally involved in fibrinogen desorption and a synergism may exist between HK and that protein.
已经描述了表面上纤维蛋白原的瞬时检测(弗罗曼效应),并且已证明高分子量激肽原(HK)在该反应中起作用。在本研究中,我们试图确定负责阻止最初从血浆吸附到各种人工表面的纤维蛋白原被检测到的HK形式,并确定是否有其他血浆成分参与其中。我们比较了在正常血浆存在下与缺乏特定蛋白质的血浆中125I-纤维蛋白原的吸附情况。在所有测试的表面上,我们发现纤维蛋白原从表面被置换。然而,置换程度大大降低,但在缺乏HK的血浆中并未消除。缺乏因子XII的血浆也显示出纤维蛋白原置换减少。这些数据表明HK实际上可以置换纤维蛋白原;然而,因子XII或因子XII介导的反应对于这种置换的发生似乎也是必需的。此外,当正常血浆首先通过硫酸葡聚糖进行广泛的接触激活时,在此过程中HK被广泛降解为小于轻链的成分(通过蛋白质印迹法评估),我们观察到纤维蛋白原的置换大大减少。然而,对缺乏因子XI的血浆进行广泛的接触激活未能显示出低分子量衍生物,并且纤维蛋白原的置换与未经历广泛激活的正常血浆相似。这些数据表明HKa(由因子XIIa或激肽释放酶在接触激活过程中产生的活性辅因子)主要负责置换纤维蛋白原,而HKi(由因子XIa产生的无活性辅因子)不能置换纤维蛋白原。通过蛋白质印迹分析,所有血浆样品中的纤维蛋白原看起来相似,这表明纤维蛋白原降解不是弗罗曼效应的组成部分。此外,用在赖氨酸琼脂糖上预色谱分离的血浆进行的实验表明,一种可被赖氨酸琼脂糖吸附的蛋白质可能极少参与纤维蛋白原的解吸附,并且HK与该蛋白质之间可能存在协同作用。